Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-10-12Clinical Trial Update: Caelyx as Primary Treatment for Patients With Breast Cancer and a History of Heart Disease and/or Age Over 65 Years [Phase 2]
A Phase 2 trial of Caelyx as first-line therapy for breast cancer in patients with cardiovascular risk factors or age over 65 has completed.
-
CLINICAL_TRIALS trial_result · 2017-10-12Clinical Trial Update: Dose Dense TC + Pegfilgrastim Support for Breast Cancer [Phase 2]
Phase 2 trial evaluating dose-dense paclitaxel (TC) with pegfilgrastim support in female breast cancer has completed with results posted in …
-
CLINICAL_TRIALS trial_result · 2017-10-12Clinical Trial Update: Study Into the Use of Electrical Impedance Mammography in the Diagnosis and Characterisation of Breast Disease
The clinical trial evaluating electrical impedance mammography for the diagnosis and characterization of breast disease has been terminated.
-
CLINICAL_TRIALS trial_result · 2017-10-12Clinical Trial Update: Robot Assisted Mastectomy Via Axillary Way With Areola Conservation and Immediate Reconstruction [Phase 2]
Phase 2 trial evaluating robot-assisted mastectomy via axillary approach with areola conservation and immediate reconstruction for breast ca…
-
CLINICAL_TRIALS trial_result · 2017-10-11Clinical Trial Update: Pilot Study to Determine Radioiodide Accumulation and Dosimetry in Breast Cancers Using 124I PET/CT [EARLY_Phase 1]
Terminated early-phase study evaluating radioiodide accumulation and dosimetry in breast cancers using 124I PET/CT.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-10-11Clinical Trial Update: Overall Diet Quality and Breast Cancer Risk
ClinicalTrials.gov notes that the study on overall diet quality and breast cancer risk has completed.
-
CLINICAL_TRIALS trial_result · 2017-10-09Clinical Trial Update: Study Evaluating The Effects Of Neratinib After Adjuvant Trastuzumab In Women With Early Stage Breast Cancer [Phase 3]
Phase 3 trial evaluating neratinib after adjuvant trastuzumab in women with early-stage breast cancer has completed with results posted in 2…
-
CLINICAL_TRIALS trial_result · 2017-10-06Clinical Trial Update: Sleep, Circadian Hormonal Dysregulation, and Breast Cancer Survival
Clinical trial investigating the relationship between sleep patterns, circadian hormonal dysregulation, and survival in individuals with bre…
-
CLINICAL_TRIALS trial_result · 2017-10-06Clinical Trial Update: A Pilot Study of a Brief Pre-Operative Intervention for Patients Undergoing Breast Surgery [NA]
The document reports the completion of a pilot study evaluating a brief pre-operative intervention for patients undergoing breast cancer sur…
-
CLINICAL_TRIALS trial_result · 2017-10-02Clinical Trial Update: Education With or Without Exercise and Counseling in Preventing Lymphedema in Women With Stage I, Stage II, or Stage III Breast Cancer Who Are Undergoing Axillary Lymph Node Dissection [Phase 3]
Phase 3 trial evaluating education with or without exercise and counseling to prevent lymphedema in women with Stage I-III breast cancer und…
-
CLINICAL_TRIALS trial_result · 2017-10-02Clinical Trial Update: Home-Based Symptom Management Via Reflexology for Breast Cancer Patients [NA]
This trial investigated home-based reflexology for symptom management in breast cancer patients. The study completed and results were posted…
-
CLINICAL_TRIALS trial_result · 2017-09-29Clinical Trial Update: Romidepsin and Abraxane in Treating Patients With Metastatic Inflammatory Breast Cancer [Phase 1, Phase 2]
A Phase 1/2 trial of romidepsin plus Abraxane in HER2-negative inflammatory and metastatic breast cancer was terminated, with results posted…
-
CLINICAL_TRIALS trial_result · 2017-09-27Clinical Trial Update: Vitamin D in Postmenopausal Women at High Risk for Breast Cancer [Phase 2]
Phase 2 clinical trial update on vitamin D in postmenopausal women at high risk for breast cancer completed with results posted.
-
CLINICAL_TRIALS trial_result · 2017-09-26Clinical Trial Update: External-Beam Partial-Breast Irradiation for Early Breast Cancer 40 Gy QD Over 2 Weeks [NA]
Clinical trial completion update for external-beam partial-breast irradiation (40 Gy once daily over 2 weeks) in breast cancer; results post…
-
CLINICAL_TRIALS trial_result · 2017-09-25Clinical Trial Update: FLT PET in Measuring Treatment Response in Patients With Newly Diagnosed Estrogen Receptor-Positive, HER2-Negative Stage I-III Breast Cancer [NA]
The document reports the completion of a clinical trial evaluating FLT PET to measure treatment response in newly diagnosed estrogen recepto…
-
CLINICAL_TRIALS trial_result · 2017-09-18Clinical Trial Update: Exercise and Metformin in Colorectal and Breast Cancer Survivors [Phase 2]
Phase 2 clinical trial update evaluating exercise plus metformin in colorectal and breast cancer survivors. The study is completed and resul…
-
CLINICAL_TRIALS trial_result · 2017-09-18Clinical Trial Update: Chemotherapy With or Without Bevacizumab in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer That Can Be Removed By Surgery [Phase 3]
Phase 3 trial evaluating chemotherapy with or without bevacizumab in surgically removable stage I–IIIA breast cancer; results posted in 2017…
-
CLINICAL_TRIALS trial_result · 2017-09-18Clinical Trial Update: Evaluation of Half-Dose Molecular Breast Imaging With Wide Beam Reconstruction Processing [NA]
Clinical trial update reporting completion of a study evaluating half-dose molecular breast imaging with wide beam reconstruction processing…
-
CLINICAL_TRIALS trial_result · 2017-09-14Clinical Trial Update: Carboplatin, Paclitaxel, and Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Breast Cancer [Phase 2]
Phase 2 trial evaluating carboplatin, paclitaxel, and bevacizumab in locally recurrent or metastatic breast cancer has completed with result…
-
CLINICAL_TRIALS trial_result · 2017-09-14Clinical Trial Update: Second-line Endocrine Treatment Followed by Capecitabine Versus Capecitabine Followed by Endocrine Treatment in Patients With Metastatic ER Positive Breast Cancer [Phase 2, Phase 3]
A trial comparing sequences of endocrine therapy and capecitabine in metastatic ER-positive breast cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2017-09-13Clinical Trial Update: Abraxane With or Without Tigatuzumab in Patients With Metastatic, Triple Negative Breast Cancer [Phase 2]
A completed Phase 2 trial evaluating Abraxane with or without Tigatuzumab in metastatic triple-negative breast cancer. Results have been pos…
-
CLINICAL_TRIALS trial_result · 2017-09-11Clinical Trial Update: Lapatinib Ditosylate, Trastuzumab, Paclitaxel, and Surgery in Treating Patients With Breast Cancer [Phase 2]
Phase 2 trial evaluating lapatinib ditosylate plus trastuzumab, paclitaxel, and surgery for HER2-positive breast cancer completed with resul…
-
CLINICAL_TRIALS trial_result · 2017-09-06Clinical Trial Update: Lapatinib Plus Chemotherapy Versus Trastuzumab Plus Chemotherapy in HER2-positive Breast Cancer [Phase 2]
Phase 2 trial comparing lapatinib plus chemotherapy to trastuzumab plus chemotherapy in HER2-positive breast cancer.
-
CLINICAL_TRIALS trial_result · 2017-09-05Clinical Trial Update: Optimal Duration of Pre-operative Treatment With Letrozole and to Correlate Clinical Efficacy With Appropriate Surrogate Markers [Phase 2, Phase 3]
Phase 2/3 trial update evaluating optimal duration of pre-operative letrozole and correlation of clinical efficacy with surrogate markers in…
-
CLINICAL_TRIALS trial_result · 2017-08-31Clinical Trial Update: Doxorubicin Hydrochloride, Cyclophosphamide, and Filgrastim Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation With or Without Trastuzumab in Treating Patients With Breast Cancer Previously Treated With Surgery [Phase 2]
A Phase 2 trial evaluating a multi-drug regimen (doxorubicin hydrochloride, cyclophosphamide, filgrastim) followed by paclitaxel albumin-sta…